Glenmark Pharmaceuticals Balance Sheet Annual

Trade
BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | Sector: Biotechnology & Drugs
1,493.45 +13.40 (0.91%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Cash 1,658.271,159.201,410.531,138.10
Short Term Investments 173.60130.00--
Cashand Short Term Investments 1,831.871,289.201,410.531,138.10
Accounts Receivable- Trade Net 1,858.413,665.173,101.142,572.06
Total Receivables Net 1,858.413,665.173,935.853,415.18
Total Inventory 2,513.052,373.622,679.502,546.30
Other Current Assets Total 1,224.751,095.6536.6240.23
Total Current Assets 7,428.088,423.648,282.357,359.58
Property/ Plant/ Equipment Total- Net 3,537.484,195.104,611.724,175.57
Goodwill Net 67.3673.6260.0258.01
Intangibles Net 1,267.212,342.682,225.382,276.94
Long Term Investments 859.5576.2549.6224.63
Other Long Term Assets Total 1,198.954,260.391,725.981,599.45
Total Assets 14,358.6219,371.6817,083.2915,603.58
Accounts Payable 2,535.932,000.432,317.092,248.17
Current Portof LT Debt/ Capital Leases 1,079.24578.62820.28359.85
Other Currentliabilities Total 2,203.421,967.20599.16569.48
Total Current Liabilities 5,818.594,546.244,689.434,201.02
Long Term Debt 0.003,852.142,571.743,888.82
Capital Lease Obligations 151.69177.12199.99224.04
Total Long Term Debt 151.694,029.262,771.744,112.85
Total Debt 1,230.934,607.883,962.024,985.72
Deferred Income Tax 0.280.5131.5028.75
Minority Interest -0.38365.34351.47-0.35
Other Liabilities Total 540.52956.40152.50196.68
Total Liabilities 6,510.709,897.757,996.648,538.95
Common Stock Total 28.2228.2228.1228.22
Retained Earnings( Accumulated Deficit) 7,819.719,445.719,392.927,420.86
Total Equity 7,847.939,473.929,086.657,064.63
Total Liabilities Shareholders' Equity 14,358.6219,371.6817,083.2915,603.58
Total Common Shares Outstanding 28.2228.2228.2228.22
Tangible Book Valueper Share Common Eq 230.81250.12241.04167.62
Property/ Plant/ Equipment Total- Gross -1,065.826,616.195,843.25
Notes Payable/ Short Term Debt -0.00370.00513.02
Prepaid Expenses --219.86219.78
Accumulated Depreciation Total ---2,004.47-1,667.68
Note Receivable- Long Term --128.22109.40
Accrued Expenses --582.90510.51
Additional Paid- In Capital --1,685.361,685.36
Other Equity Total ---2,019.75-2,069.81
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts